COM:NRXPHARMA

NRx Pharmaceuticals

Stock

USD

Last Close

1.23

22/11 21:00

Market Cap

25.25M

Beta: -

Volume Today

79.90K

Avg: -

Overview Metrics Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income		66.10K -	408.43K 517.88%	-51.78M 12,777.17%	-93.06M 79.74%	-39.75M 57.28%	-30.15M 24.16%
depreciation and amortization			0.86 -	2K 232,728.87%	2K 0%	4K 100%	5K 25%
deferred income tax			70.41K -	5.72M 8,019.93%	-1.81M 131.71%		-2.65M -
stock based compensation			933.90 -	730K 78,066.49%	7.79M 966.44%	3.63M 53.40%	387K 89.33%
change in working capital	-35.51K -	-980.42K 2,660.97%	4.66K 100.48%	3.45M 73,966.92%	-4.90M 241.85%	699K 114.27%	5.16M 638.77%
accounts receivables				-831K -	831K 200%
inventory
accounts payables		465.43K -	71.34K 84.67%	1.18M 1,558.21%	-19K 101.61%	-1.61M 8,378.95%	2.65M 264.80%
other working capital	-35.51K -	-1.45M 3,971.67%	-66.68K 95.39%	3.10M 4,750.57%	-5.71M 284.13%	2.31M 140.46%	2.51M 8.61%
other non cash items	-100.30K -	441.13K 539.81%	-1.28M 389.52%	39.61M 3,201.41%	54.28M 37.05%	-4.33M 107.98%	5.59M 229.09%
net cash provided by operating activities	-135.81K -	-473.19K 248.42%	-792.73K 67.53%	-2.27M 185.72%	-37.70M 1,564.59%	-39.76M 5.44%	-21.66M 45.52%
investments in property plant and equipment			-3.55 -	-2K 56,206.31%	-7K 250%	-10K 42.86%
acquisitions net
purchases of investments		-690K -	-993.10K 43.93%		-7K -	-10K 42.86%	-3K 70%
sales maturities of investments		42.39K -	41.24M 97,181.75%
other investing activites	-69M -		3.55 -		7K -	10K 42.86%
net cash used for investing activites	-69M -	-647.61K 99.06%	40.25M 6,314.65%	-2K 100.00%	-7K 250%	-10K 42.86%	-3K 70%
debt repayment			-1.26M -	-620K 50.86%	-1.28M 105.81%	-518K 59.40%	-3.09M 496.91%
common stock issued				2.58M -	36.98M 1,334.01%	22.70M 38.62%	9.29M 59.07%
common stock repurchased	70.03M -		-40.73M -
dividends paid
other financing activites	-439.92K -	682.50K 255.14%	5.80K 99.15%	1.29M 22,133.70%	27.75M 2,051.09%	10.03M 63.85%	5.03M 49.85%
net cash used provided by financing activities	69.59M -	682.50K 99.02%	-39.46M 5,882.41%	3.25M 108.23%	63.46M 1,853.09%	32.21M 49.23%	6.20M 80.75%
effect of forex changes on cash			11.95K -
net change in cash	449.37K -	-438.30K 197.54%	-11.07K 97.47%	982K 8,968.42%	25.75M 2,521.79%	-7.55M 129.33%	-15.46M 104.73%
cash at beginning of period		449.37K -	11.08K 97.53%	877K 7,815.88%	1.86M 111.97%	27.61M 1,384.94%	20.05M 27.35%
cash at end of period	449.37K -	11.08K 97.53%	6 99.95%	1.86M 30,983,233.33%	27.61M 1,384.94%	20.05M 27.35%	4.59M 77.09%
operating cash flow	-135.81K -	-473.19K 248.42%	-792.73K 67.53%	-2.27M 185.72%	-37.70M 1,564.59%	-39.76M 5.44%	-21.66M 45.52%
capital expenditure			-3.55 -	-2K 56,206.31%	-7K 250%	-10K 42.86%
free cash flow	-135.81K -	-473.19K 248.42%	-792.73K 67.53%	-2.27M 185.97%	-37.71M 1,563.43%	-39.77M 5.45%	-21.66M 45.54%

All numbers in USD (except ratios and percentages)